Ophthalmic Case Studies and Novel Approach

In a recent small-scale randomized controlled trial, the Oculeve Intranasal Lacrimal Neurostimulator (Allergan) was found to increase the production of aqueous tears and the secretion of goblet cells. This handheld device functions by administering electrical stimulation to the anterior ethmoidal branch of the trigeminal nerve within the nasal cavities. This innovative approach presents a potential new avenue for managing dry eye disease, which currently relies heavily on artificial tears and anti-inflammatory medications.

    Related Conference of Ophthalmic Case Studies and Novel Approach

    September 16-17, 2025

    20th International Conference on Ophthalmology and Vision Science

    Amsterdam, Netherlands
    September 22-23, 2025

    8th International Eye and Vision Congress

    Amsterdam, Netherlands
    October 20-21, 2025

    6th World Congress on Ophthalmology and Vision Science

    Barcelona, Spain
    November 03-04, 2025

    39th European Ophthalmology Congress

    Rome, Italy
    January 12-13, 2026

    26th Global Ophthalmologists Annual Meeting

    London, UK
    April 20-21, 2026

    3rd International Conference on Ophthalmology

    Barcelona, Spain
    May 07-08, 2026

    7th International Conference on Optometry

    Paris, France
    May 25-26, 2026

    10th World Congress on Eye and Vision

    Madrid, Spain

    Ophthalmic Case Studies and Novel Approach Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in